TP

Servier announces outcome from the primary analysis of the Phase III SOLSTICE trial assessing LONSURF® (trifluridine/tipiracil) + bevacizumab in a 1st line setting for patients with unresectable mCRC non-eligible for intensive therapy

Friday, October 22, 2021 - 8:00am

SOLSTICE was designed to evaluate the superiority of LONSURF (trifluridine/tipiracil) + bevacizumab over capecitabine + bevacizumab in 1st line unresectable metastatic colorectal cancer (mCRC) in patients non-eligible for intensive therapy.

Key Points: 
  • SOLSTICE was designed to evaluate the superiority of LONSURF (trifluridine/tipiracil) + bevacizumab over capecitabine + bevacizumab in 1st line unresectable metastatic colorectal cancer (mCRC) in patients non-eligible for intensive therapy.
  • D., Head of Late Stage and Life Cycle Management, and Deputy Head Oncology and Immuno-Oncology Therapeutic Area, Servier.
  • The clinical value of LONSURF in its current indications remains unchanged, and the ongoing Phase III SUNLIGHT trial (LONSURF + bevacizumab versus LONSURF in 3rd line mCRC) is proceeding as planned.
  • SOLSTICE is an open-label, randomized, multicentre Phase III trial in 856 unresectable metastatic colorectal cancer patients who are not candidates for, or do not require, intensive therapy.

Global ESG Investing Surge Drives Growth for Data and Index Providers- Two New Burton-Taylor Reports

Wednesday, October 20, 2021 - 1:30pm

Burton-Taylor today announced the publication of two new reports covering both the ESG index and data industries.

Key Points: 
  • Burton-Taylor today announced the publication of two new reports covering both the ESG index and data industries.
  • The ESG Index report analyzes global revenues by provider and gives insight into the drivers of ESG index growth.
  • The ESG Data/Analytics report looks at the increasing role ESG data/analytics is playing in capital markets and how data providers are reacting to the change.
  • Burton-Taylor Exchange, Index, AML/KYC, Media Intelligence/PR and Market Data share figures are seen as the industry benchmark standard globally.

Bloomberg and Kaiko Issue First Financial Instrument Global Identifiers for Crypto Assets

Thursday, October 14, 2021 - 1:00pm

NEW YORK, Oct. 14, 2021 /PRNewswire/ --Bloomberg and Kaiko are pleased to announce the issuance of the first series of Financial Instrument Global Identifiers covering crypto assets.

Key Points: 
  • NEW YORK, Oct. 14, 2021 /PRNewswire/ --Bloomberg and Kaiko are pleased to announce the issuance of the first series of Financial Instrument Global Identifiers covering crypto assets.
  • The Financial Instrument Global Identifier (FIGI) is an open standard of the Object Management Group (OMG), for the issuance of unique identifiers assigned to financial instruments including equities, derivatives, bonds, municipals, and currencies.
  • Today, Kaiko and Bloomberg officially released the first batch of FIGIs for all Bitcoin and Ethereum instruments denominated in fiat currencies.
  • FIGIs for crypto assets enable interoperability between industry participants such as digital asset exchanges, data aggregators, custodians, service providers, and regulators.

What is TRX? Everything You Need to Know about TRON

Wednesday, October 13, 2021 - 6:00am

This time, we'll be looking at TRON Network and its native coin, Tronix (TRX).

Key Points: 
  • This time, we'll be looking at TRON Network and its native coin, Tronix (TRX).
  • - TRON's DApp ecosystem reached more than 80 Dapps in 60 days of the TRON Virtual Machine (TVM) launch.
  • TRON network also has no lock period when unstaking and practically zero transaction fees, making it a popular blockchain for many users.
  • You can claim your TRX rewards once every 24 hours directly from the TRON network via Moonstake Wallet.

Moonstake Wallet Now Supports Staking of TRON (TRX)

Wednesday, October 6, 2021 - 5:00am

Starting today, users can stake TRX to earn staking rewards on Moonstake Web Wallet and mobile wallet!

Key Points: 
  • Starting today, users can stake TRX to earn staking rewards on Moonstake Web Wallet and mobile wallet!
  • After Cosmos, IRISnet, Ontology, Harmony, Tezos, Cardano, Qtum, Polkadot, Quras, Centrality, Orbs, and IOST, TRON became the 13th available staking coin on Moonstake.
  • Moonstake started the staking business last year with the aim to create the largest staking network in Asia.
  • From the Staking tab, click the "Staking" button and enter your wallet password to complete staking.

Takkion Acquires Airway Services

Tuesday, October 5, 2021 - 8:44pm

DALLAS, Oct. 5, 2021 /PRNewswire/ --Takkion TP&L Holdings LLC ("Takkion" or the "Company"), a portfolio company of funds managed by affiliates of Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, "Apollo") today announced that it has acquired San Angelo, TX-based Airway Services, LLC ("Airway Services", or "Airway"), from family office-backed private investment firms Northaven Capital Partners and Concentric Equity Partners.

Key Points: 
  • DALLAS, Oct. 5, 2021 /PRNewswire/ --Takkion TP&L Holdings LLC ("Takkion" or the "Company"), a portfolio company of funds managed by affiliates of Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, "Apollo") today announced that it has acquired San Angelo, TX-based Airway Services, LLC ("Airway Services", or "Airway"), from family office-backed private investment firms Northaven Capital Partners and Concentric Equity Partners.
  • Takkion has acquired Airway Services to expand its solutions for the renewable energy services market.
  • Airway Services will complement Takkion's leading multimodal logistics and O&M services companies: Transportation Partners and Logistics ("TP&L"), Global Specialized Services ("GSS") and Renew Energy ("RENEW").
  • Jim Orr, President and Chief Executive Officer of Takkion, added, "We are excited to add Airway Services to the Takkion platform of companies.

Sequana Medical announces FDA approval to expand patient enrolment in North American pivotal alfapump® study (POSEIDON)

Monday, October 4, 2021 - 6:00am

The study allows for up to 35 patients to be enrolled in a Roll-In Cohort, to ensure centres are experienced with the alfapump implantation prior to enrolment of patients in the Pivotal Cohort.

Key Points: 
  • The study allows for up to 35 patients to be enrolled in a Roll-In Cohort, to ensure centres are experienced with the alfapump implantation prior to enrolment of patients in the Pivotal Cohort.
  • A detailed review of study enrolment in H1 2021, including an analysis of attrition between study enrolment and planned alfapump implantation, identified a higher rate of attrition than forecast when the study was planned.
  • Interim data from the ongoing North American pivotal study (POSEIDON) showed positive outcomes against all primary endpoints of the study and a rapid and persistent clinically important improvement in quality of life.
  • Sequana Medical has combined its proven alfapump and proprietary DSR therapy, and is developing the alfapump DSR, a breakthrough approach to fluid overload due to heart failure.

Ai & ML Pricing Engines Becoming Indispensable Tool For Participants In The Us Credit Markets - New Burton- Taylor Report

Thursday, September 30, 2021 - 1:30pm

Advances in Ai/ML pricing has been key to improving automation efficacy and broader fixed income market applicability.

Key Points: 
  • Advances in Ai/ML pricing has been key to improving automation efficacy and broader fixed income market applicability.
  • Burton-Taylor today announced the publication of a new report covering the role of Ai / ML in corporate bond pricing.
  • The Machine Learning and the Bond Market Evolutionreport analyzes how Ai and ML are improving pricing accuracy and revolutionizing a market that has been late to adopt advanced technology.
  • Burton-Taylor Exchange, Credit, Risk, Compliance, Media Intelligence, PR and Market Data share figures are seen as industry benchmark standard globally.

Global Inter-Dealer Broker Market Data Revenues Increased 9.3% To A Record $309.3 Million In 2020 Driven By FX And Interest Rate Data-new Burton-Taylor Report

Wednesday, September 15, 2021 - 1:30pm

Pandemic driven budget constraints have driven IDBs to be more creative in data delivery and storage, answering customer calls for decreased cost of ownership.

Key Points: 
  • Pandemic driven budget constraints have driven IDBs to be more creative in data delivery and storage, answering customer calls for decreased cost of ownership.
  • Over 85% of total IDB market data spend is allocated to TP ICAP and BGC Partners, the two largest IDBs in the world.
  • The IDB Market Data Industry 2021: The Next Frontier in OTC Market Data report analyzes the four major
    IDBs of today, offering perspective on differentiating factors ranging from product offerings to technological advancements.
  • Burton-Taylor Exchange, Credit, Risk, Compliance, Media Intelligence, PR and Market Data share figures are seen as industry benchmark standard globally.

Emerald Brand Accredited Sales Group Inks Deal With Tissue Plus Manufacturing

Thursday, September 9, 2021 - 8:00pm

HUNTINGTON, N.Y., Sept. 9, 2021 /PRNewswire-PRWeb/ --Next Generation Solutions, LLC (NGS), an Emerald Brand Accredited sales organization, concluded an agreement for exclusive representation with Tissue Plus, LLC (TP) for manufacturing capacity.

Key Points: 
  • HUNTINGTON, N.Y., Sept. 9, 2021 /PRNewswire-PRWeb/ --Next Generation Solutions, LLC (NGS), an Emerald Brand Accredited sales organization, concluded an agreement for exclusive representation with Tissue Plus, LLC (TP) for manufacturing capacity.
  • NGS, an independent sales and consulting group of Emerald Brand, has signed a multi-year exclusive, representing all capacity out of the Tissue Plus plants in both Maine and Maryland.
  • "This sales and consulting agreement will accelerate the production output that TP has on 12 lines of towel, tissue and napkins.
  • A combined Tissue Plus experience in production, and Emerald Brand's innovative R&D expertise will allow us to continue to maintain the quality our clients expect, while securing capacity for all Emerald Brand "TREE-FREE" paper products on the Eastern seaboard of the USA," states Ralph Bianculli, Sr., CEO of Emerald Brand.